NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 194 filers reported holding NOVAVAX INC in Q2 2016. The put-call ratio across all filers is 2.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $14,000 | -87.4% | 11,068 | -87.4% | 0.00% | -100.0% |
| Q4 2016 | $111,000 | -84.9% | 88,081 | -75.0% | 0.00% | -83.3% |
| Q3 2016 | $733,000 | +338.9% | 352,394 | +1437.7% | 0.01% | +1100.0% |
| Q2 2016 | $167,000 | +96.5% | 22,917 | +38.8% | 0.00% | 0.0% |
| Q1 2016 | $85,000 | -58.3% | 16,507 | -32.1% | 0.00% | -50.0% |
| Q4 2015 | $204,000 | +59.4% | 24,295 | +57.0% | 0.00% | +100.0% |
| Q1 2015 | $128,000 | -7.9% | 15,474 | -49.6% | 0.00% | 0.0% |
| Q1 2014 | $139,000 | +90.4% | 30,706 | -13.7% | 0.00% | – |
| Q2 2013 | $73,000 | – | 35,598 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Caption Management, LLC | 2,021,600 | $22,273,000 | 1.23% |
| GREAT POINT PARTNERS LLC | 4,500,000 | $2,479,000 | 0.24% |
| SABBY MANAGEMENT, LLC | 860,000 | $474,000 | 0.23% |
| Sargent Investment Group, LLC | 588,070 | $324,000 | 0.16% |
| BB BIOTECH AG | 8,330,000 | $4,589,000 | 0.12% |
| GREAT POINT PARTNERS LLC | 2,000,000 | $1,102,000 | 0.11% |
| CENTAURUS FINANCIAL, INC. | 7 | $12,000,000 | 0.07% |
| Rock Springs Capital Management LP | 3,250,000 | $1,790,000 | 0.07% |
| Beirne Wealth Consulting Services, LLC | 155,000 | $85,000 | 0.07% |
| ACUTA CAPITAL PARTNERS, LLC | 250,000 | $138,000 | 0.07% |